Economy

November 13, 2013

Critics say U.S. is going too far to protect drug companies in trade talks

Critics of a plan to expand trade in the Pacific Rim today accused the Obama administration of pushing terms that would benefit U.S. pharmaceutical companies while raising drug prices. Their assessment is based on an analysis of new documents published by WikiLeaks.

Related content

Comments

Videos